DrFirst’s SmartRenewal was named a finalist in the Edison Awards this week, recognizing the solution’s innovative use of artificial intelligence (AI) to improve efficiency for healthcare providers and safety for patients. For the second consecutive year, the Edison Awards recognizes DrFirst’s pioneering use of AI to make clinical workflows more efficient and medication errors less likely.
While healthcare industry standards attempt to make data accessible across disparate computer systems, interoperability remains a challenge, and transmitted data is often not understood by receiving systems. SmartRenewal uses patented AI technology to bridge the interoperability gap so clinicians can renew prescriptions without the manual clicks and keystrokes previously required to import medication details into discrete fields in the electronic health record (EHR) system.
“Manually entering prescription data is not only tedious and time-consuming – it’s also dangerous,” said G. Cameron Deemer, CEO of DrFirst. “We’re pleased that the award judges recognize the impact of making data accessible and usable across provider and pharmacy systems. Doing so is vital for physicians to renew prescriptions quickly and safely and get medications into patients’ hands sooner.”
From nearly 400 nominations, this year’s Edison Awards finalists were chosen by senior business executives and industry experts from around the globe.
“Innovation is critical to every company,” said Frank Bonafilia, executive director, Edison Awards. “The 2023 Edison Awards Finalists all found a better way to improve consumers’ lives by designing the future.”
The awards are named for Thomas A. Edison, whose extraordinary contributions garnered 1,093 U.S. patents, pioneered multiple industries, and made him a household name worldwide.
SOURCE: PR Newswire